Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alaunos Therapeutics (TCRT) Shares Outstanding (2016 - 2025)

Alaunos Therapeutics (TCRT) has disclosed Shares Outstanding for 15 consecutive years, with $850.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding fell 99.95% year-over-year to $850.0, compared with a TTM value of $850.0 through Sep 2025, down 99.95%, and an annual FY2024 reading of $1.6 million, down 90.0% over the prior year.
  • Shares Outstanding was $500.0 for Q3 2025 at Alaunos Therapeutics, down from $2.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $240.6 million in Q2 2023 and bottomed at $500.0 in Q3 2025.
  • Average Shares Outstanding over 5 years is $82.5 million, with a median of $1.6 million recorded in 2023.
  • The sharpest move saw Shares Outstanding increased 0.92% in 2021, then crashed 99.97% in 2025.
  • Year by year, Shares Outstanding stood at $14.4 million in 2021, then crashed by 88.88% to $1.6 million in 2022, then fell by 0.09% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then tumbled by 99.95% to $850.0 in 2025.
  • Business Quant data shows Shares Outstanding for TCRT at $850.0 in Q3 2025, $500.0 in Q2 2025, and $1.6 million in Q1 2025.